Efficacy of Liraglutide Application in Patients with Diabetes Mellitus Type 2 and Obesity in Real Clinical Practice (Literature Review the and Findings of Our Own Observations)
This review deals with the most important issues of current endocrinology — diabetes mellitus and obesity. Attention is given to a new class of antihyperglycemic agents — incretins, particularly liraglutide. Fast, stable, and a significant reduction of body weight in the treatment of patients with d...
Main Author: | |
---|---|
Format: | Article |
Language: | English |
Published: |
Publishing House Zaslavsky
2014-09-01
|
Series: | Mìžnarodnij Endokrinologìčnij Žurnal |
Subjects: | |
Online Access: | http://iej.zaslavsky.com.ua/article/view/76942 |
Summary: | This review deals with the most important issues of current endocrinology — diabetes mellitus and obesity. Attention is given to a new class of antihyperglycemic agents — incretins, particularly liraglutide. Fast, stable, and a significant reduction of body weight in the treatment of patients with diabetes mellitus type 2, who suffer from obesity, as well as the findings of phase II clinical trial, which enrolled volunteers with obesity, enable not only to consider liraglutide as a drug used for diabetes treatment, but also to set it for drug therapy of obesity. |
---|---|
ISSN: | 2224-0721 2307-1427 |